Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. Range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range
Alexander Haese, Robert T. Dworschack, Alan W. Partin
Dive into the research topics of 'Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. Range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range'. Together they form a unique fingerprint.